Cargando…
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects
BACKGROUND: UV-4 (N-(9’-methoxynonyl)-1-deoxynojirimycin, also called MON-DNJ) is an iminosugar small-molecule oral drug candidate with in vitro antiviral activity against diverse viruses including dengue, influenza, and filoviruses and demonstrated in vivo efficacy against both dengue and influenza...
Autores principales: | Callahan, Michael, Treston, Anthony M., Lin, Grace, Smith, Marla, Kaufman, Brian, Khaliq, Mansoora, Evans DeWald, Lisa, Spurgers, Kevin, Warfield, Kelly L., Lowe, Preeya, Duchars, Matthew, Sampath, Aruna, Ramstedt, Urban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387934/ https://www.ncbi.nlm.nih.gov/pubmed/35939501 http://dx.doi.org/10.1371/journal.pntd.0010636 |
Ejemplares similares
-
The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice
por: Warfield, Kelly L., et al.
Publicado: (2016) -
In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4
por: Stavale, Eric J., et al.
Publicado: (2015) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
por: Warfield, Kelly L., et al.
Publicado: (2016) -
A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
por: Warfield, Kelly L., et al.
Publicado: (2015) -
Iminosugars: A host-targeted approach to combat Flaviviridae infections
por: Evans DeWald, Lisa, et al.
Publicado: (2020)